Reducing disability following hospital discharge in vulnerable older adults: the CAPABLE intervention

减少弱势老年人出院后的残疾:CAPABLE 干预措施

基本信息

  • 批准号:
    9980253
  • 负责人:
  • 金额:
    $ 62.42万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-09-01 至 2022-04-30
  • 项目状态:
    已结题

项目摘要

Two thirds of the 7 million older adults discharged from the hospital annually face new difficulty with activities of daily living (ADLs) that do not resolve by 12 months. To date there has been scant investigation of integrated health and housing interventions to improve physical function. Our proposed trial addresses this scientific gap. It builds upon results from our Center for Medicare and Medicaid Innovation Challenge grant. The older adults hospitalized in the previous year (N=78) who received the CAPABLE intervention, which combines evidence- based nursing, occupational therapy, and handyman components, reported difficulty with 41% fewer ADLs at 5 month follow-up than baseline. An improvement of this magnitude could make the difference between aging at home independently and needing institutional care. The proposed study will target this vulnerable group to provide new reproducible knowledge about improving physical function after skilled care using a rigorous pragmatic trial design. We propose to test the effectiveness of CAPABLE in older adults for whom recovery time and typical treatment were not sufficient to regain their functional ability. These individuals will be at least 60 days post-hospital discharge, have completed the skilled home health care allowed by Medicare, and still have difficulties with ADLs. We will recruit older (≥age 65), principally Latino and African American adults with ≥ 1 ADL difficulties from the Visiting Nurse Service of New York City Medicare Advantage population. We will interview participants at home and randomize them to either treatment (CAPABLE intervention) or control (usual care). Participants in the treatment group will receive up to 10 in-home sessions - ≤6 visits with an occupational therapist and ≤4 visits from a nurse – and ≤$1500 in safety and modification services from a licensed handyman. Each treatment participant will receive each intervention component (education, assessment, identification of functional goals, specific strategies tailored to goals and based on protocols). Participants in the usual care group will not receive grant related attention. All participants will be reassessed at 20 and 52 weeks by a research assistant masked to treatment condition. The primary aims of the study are to: 1) test the effectiveness of CAPABLE in reducing the number of ADLs performed with difficulty at 20 weeks post-randomization; and 2) estimate CAPABLE’s economic impact on subsequent health care utilization and costs over 1 year post-randomization compared to CAPABLE program cost. Our secondary aims include: 1) testing CAPABLE effectiveness on ADL function at 52 weeks; 2) testing effects for key subgroups (gender, ethnicity); and 3) examining theoretically-driven mediation pathways for treatment mechanisms. The proposed study would create new knowledge to improve function following hospitalization. Our approach responds to NIA’s strategic goals to understand disability and to improve the health of diverse older populations. Our approach also has timely policy relevance in promoting aging in place in an aging population.
每年从医院出院的700万老年人中有三分之二面临新的活动困难, 日常生活能力(ADL)在12个月内未消退。到目前为止,对综合性的研究还很少。 健康和住房干预措施,以改善身体机能。我们提出的试验解决了这一科学空白。 它建立在我们的医疗保险和医疗补助创新挑战中心赠款的基础上。老年人 在前一年住院(N=78),接受了CAPABLE干预,结合证据- 基础护理、职业治疗和勤杂工组成部分,报告5岁时ADL困难减少41% 随访时间比基线长。这种程度的改善可能会使年龄在 独立在家,需要机构照顾。拟议的研究将针对这一弱势群体, 提供新的可重复的知识,关于使用严格的 务实的审判设计我们建议在老年人中测试CAPABLE的有效性, 时间和典型治疗不足以恢复他们的功能能力。这些人至少 出院后60天,已完成Medicare允许的熟练家庭医疗护理, 在ADL方面有困难。我们将招募年龄较大(≥ 65岁)的患者,主要是拉丁美洲和非洲裔美国成年人, 来自纽约市Medicare Advantage人群的访视护士服务的ADL困难≥ 1。我们将 在家中采访参与者,并将他们随机分配到治疗组(CAPABLE干预组)或对照组 (常规护理)。治疗组的受试者将接受最多10次家庭治疗- ≤6次访视, 职业治疗师和≤4次护士访视-以及≤ 1500美元的安全和改造服务, 有执照的勤杂工每名治疗参与者将接受每种干预成分(教育, 评估、确定功能目标、针对目标并基于协议的具体策略)。 普通护理组的参与者将不会得到与补助金有关的关注。所有参与者将重新评估 在第20和52周时由研究助理对治疗条件设盲。研究的主要目的是 目的:1)检测CAPABLE在减少20周时难以进行的ADL数量方面的有效性 随机化后; 2)估计CAPABLE对后续医疗保健利用的经济影响, 随机化后1年内的成本与CAPABLE项目成本相比。我们的次要目标包括:1) 在52周时测试CAPABLE对ADL功能的有效性; 2)测试关键亚组(性别, 种族);和3)检查治疗机制的理论驱动的调解途径。拟议 这项研究将创造新的知识,以改善住院后的功能。我们的方法响应于 NIA的战略目标是了解残疾并改善各种老年人口的健康状况。我们 在促进人口老龄化中的就地养老方面,这一方法也具有及时的政策相关性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sarah L Szanton其他文献

Complexities and actualization: embedding a home-based functional improvement intervention within a Medicaid Waiver
  • DOI:
    10.1186/1748-5908-10-s1-a69
  • 发表时间:
    2015-08-14
  • 期刊:
  • 影响因子:
    13.400
  • 作者:
    Sarah L Szanton;Sandra Spoelstra;Laura Gitlin
  • 通讯作者:
    Laura Gitlin

Sarah L Szanton的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sarah L Szanton', 18)}}的其他基金

The role structural discrimination on depression, sleep, cardiovascular disease, and cognitive decline
结构性歧视对抑郁、睡眠、心血管疾病和认知能力下降的作用
  • 批准号:
    10447383
  • 财政年份:
    2020
  • 资助金额:
    $ 62.42万
  • 项目类别:
Reducing racial disparities in AD/ADRD: Addressing structural discrimination and resilience
减少 AD/ADRD 中的种族差异:解决结构性歧视和复原力
  • 批准号:
    10094515
  • 财政年份:
    2020
  • 资助金额:
    $ 62.42万
  • 项目类别:
Hopkins Center to Promote resilience in persons and families living with multiple chronic conditions (the PROMOTE Center)
霍普金斯促进患有多种慢性病的个人和家庭的复原力中心(PROMOTE 中心)
  • 批准号:
    10475033
  • 财政年份:
    2018
  • 资助金额:
    $ 62.42万
  • 项目类别:
Hopkins Center to Promote resilience in persons and families living with multiple chronic conditions (the PROMOTE Center)
霍普金斯促进患有多种慢性病的个人和家庭的复原力中心(PROMOTE 中心)
  • 批准号:
    9768552
  • 财政年份:
    2018
  • 资助金额:
    $ 62.42万
  • 项目类别:
Hopkins Center to Promote resilience in persons and families living with multiple chronic conditions (the PROMOTE Center)
霍普金斯促进患有多种慢性病的个人和家庭的复原力中心(PROMOTE 中心)
  • 批准号:
    10214697
  • 财政年份:
    2018
  • 资助金额:
    $ 62.42万
  • 项目类别:
Reducing disability following hospital discharge in vulnerable older adults: the CAPABLE intervention
减少弱势老年人出院后的残疾:CAPABLE 干预措施
  • 批准号:
    10210236
  • 财政年份:
    2017
  • 资助金额:
    $ 62.42万
  • 项目类别:
Reducing disability following hospital discharge in vulnerable older adults: the CAPABLE intervention
减少弱势老年人出院后的残疾:CAPABLE 干预措施
  • 批准号:
    9366493
  • 财政年份:
    2017
  • 资助金额:
    $ 62.42万
  • 项目类别:
Reducing disability via a bundled bio-behavioral-environmental approach
通过捆绑的生物行为环境方法减少残疾
  • 批准号:
    9042913
  • 财政年份:
    2012
  • 资助金额:
    $ 62.42万
  • 项目类别:
Reducing disability via a bundled bio-behavioral-environmental approach
通过捆绑的生物行为环境方法减少残疾
  • 批准号:
    8443393
  • 财政年份:
    2012
  • 资助金额:
    $ 62.42万
  • 项目类别:
Reducing disability via a bundled bio-behavioral-environmental approach
通过捆绑的生物行为环境方法减少残疾
  • 批准号:
    8518784
  • 财政年份:
    2012
  • 资助金额:
    $ 62.42万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 62.42万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 62.42万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 62.42万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 62.42万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 62.42万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 62.42万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 62.42万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 62.42万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 62.42万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 62.42万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了